Inguinal hernia repair with beta glucan-coated mesh: results at two-year follow up
- 16 December 2004
- journal article
- research article
- Published by Springer Nature in Hernia
- Vol. 9 (2) , 125-130
- https://doi.org/10.1007/s10029-004-0301-y
Abstract
In a prospective study, 115 patients with a mean age of 55 years, presenting a primary or recurrent hernia were treated with a beta glucan-coated polypropylene mesh (Glucamesh). Fifty-eight underwent a Lichtenstein procedure and 57 had a laparoscopic procedure (TEP/TAPP). Oat beta glucan is an entirely natural plant product that eliminates the risk of viral or prion contamination associated with the use of collagen of animal origin. The beta glucan coated mesh is of lower weight and profile compared to a typical polypropylene implant. Preliminary results have been previously reported. With a mean follow up of 2 years, patients were evaluated by a physician and or a standardized questionnaire in order to evaluate the incidence rate of recurrence discomfort and residual chronic pain. One hundred nine (94.7%) questionnaires were returned. Of these, 104 (90.4%) were complete and analyzed. Mean follow up was 24 months (21-27). Two years after operation the recurrence rate was 1.9% (two cases: one in each group); 98 patients (94.2%) had no pain and have returned to normal activity, work and sport. Five patients (4.8%) had mild pain on moving or at rest and one (0.96%) had moderate pain at rest. There was no correlation between pain and hernia type or surgical technique. At 2 years follow up hernia repair with beta-glucan coated mesh has a low recurrence rate. Incidence of chronic pain is low. The situation is in relationship with a lightweight and smooth mesh of polypropylene and the role of oat beta glucan optimizing the healing and inclusion of the mesh into the tissues.Keywords
This publication has 27 references indexed in Scilit:
- Inguinal hernia repair with beta glucan-coated mesh: Prospective multicenter study (115 cases)?Preliminary resultsHernia, 2004
- Randomized clinical trial of lightweight composite mesh for Lichtenstein inguinal hernia repairBritish Journal of Surgery, 2004
- Comparison of biomaterials in the early postoperative periodSurgical Endoscopy, 2003
- Outcome of patients with severe chronic pain following repair of groin herniaBritish Journal of Surgery, 2002
- The Use of Glucan II in the Treatment of Donor SitesJournal of Burn Care & Rehabilitation, 2002
- Randomized clinical trial of non-mesh versus mesh repair of primary inguinal herniaBritish Journal of Surgery, 2002
- Chronic pain and quality of life following open inguinal hernia repairBritish Journal of Surgery, 2001
- Chronic pain and cutaneous sensory changes after inguinal hernia repair: comparison between open and laparoscopic techniquesHernia, 1999
- Long-term result and current status of the Lichtenstein open tension-free hernioplastyHernia, 1998
- Stimulation of human monocyte β-glucan receptors by glucan particles induces production of TNF-α and IL-1βInternational Journal of Immunopharmacology, 1992